Month: March 2022

Metal Sky Star Acquisition Corporation Announces Pricing of $100 Million Initial Public Offering

Metal Sky Star Acquisition Corporation Announces Pricing of $100 Million Initial Public Offering

NEW YORK, March 31, 2022 (GLOBE NEWSWIRE) — Metal Sky Star Acquisition Corporation, a Cayman Islands exempt company (NASDAQ: MSSAU) (the “Company”) announced today that it priced its initial public offering of 10,000,000 units at $10.00 per unit. The Company’s units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “MSSAU” beginning Friday, April 1, 2022. Each unit consists of one ordinary share, par value $0.001 per share, one right to receive one-tenth (1/10) of an ordinary share and one redeemable warrant to acquire one ordinary share at an exercise price of $11.50 per share. The underlying securities of the units are not trading separately at this time. Once the securities comprising the units begin separate trading, the shares, rights, and warrants are expected to be listed...

Continue reading

Holly Street Files Filing Statement and Obtains Conditional Approval for Qualifying Transaction with US Critical Metals Corp.

Holly Street Files Filing Statement and Obtains Conditional Approval for Qualifying Transaction with US Critical Metals Corp.

Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States. VANCOUVER, British Columbia, March 31, 2022 (GLOBE NEWSWIRE) — Holly Street Capital Ltd. (TSXV: HSC.P) (“Holly” or the “Company”), a capital pool company listed on the TSX Venture Exchange (the “Exchange”), and US Critical Metals Corp. (“USCM”) are pleased to announce that the Exchange has conditionally approved the proposed business combination (the “Proposed Transaction“) between USCM and the Company previously announced in the Company’s press releases dated November 1, 2021, January 10, 2022 and February 25, 2022. The Proposed Transaction remains subject to the final approval of the Exchange and satisfaction of closing...

Continue reading

Flow Capital Announces 2021 Annual Audited Financial Results

Flow Capital Announces 2021 Annual Audited Financial Results

Q4 Recurring Revenue from Royalties and Interest of $ 1,605,980; YTD $6,091,103 — YoY growth of 13.4% TORONTO, Ontario, March 31, 2022 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV: FW) (“Flow Capital”) announces its unaudited financial and operating results for the three-months (“Q4 2021) and year ended December 31, 2021 (“YE 2021”). 2021 Performance Highlights Book value of approximately $0.75 per share; YoY growth of 33.7%. Net income of $ 2,263,807 in Q4 2021, compared to a net loss of $(1,040,381) in Q4 2020. YTD net income of $5,597,275; YoY growth of 164%. Recurring revenue from Royalties and Interest of $ 1,605,980 in Q4 2021; YTD recurring revenue of $6,091,103; YoY growth of 13.4%. Total revenue under IFRS of $3,342,968 in Q4 2021; YTD revenue of $10,426,947; a slight year-over-year (YoY) growth of 0.5%. In YE2021,...

Continue reading

Christina Lake Cannabis Announces Late Filing of Annual Financial Statements and Management Cease Trade Order

Christina Lake Cannabis Announces Late Filing of Annual Financial Statements and Management Cease Trade Order

VANCOUVER, British Columbia, March 31, 2022 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp., (CSE: CLC)(the “Company” or “CLC”) announces today that as a result of delays to its audit, the Company’s annual financial statements and accompanying management’s discussion and analysis for the fiscal year ended November 30, 2021 (the “Annual Filings”) were not finalized by March 30, 2022, being the date that such filings are due under applicable Canadian securities law requirements. The Company has applied for, and has been granted, a management cease trade order (the “MCTO”) by the British Columbia Securities Commission. The reason for the anticipated delay is due to the complexity of the valuation process of biological assets and inventory as a result of significant operational growth in the fiscal year and enhanced...

Continue reading

Comstock Reports Fiscal Year 2021 Results

Comstock Reports Fiscal Year 2021 Results

Revenue increased 38% to $31.1 million in 2021 vs. $22.5 million in 2020 Net income from continuing operations of $16.0 million vs. $2.1 million in 2020 Adjusted EBITDA increased 68% to $5.8 million in 2021 vs. $3.4 million in 2020 Continued expansion of managed portfolio through acquisition and investment in two mixed-use, transit-oriented, luxury high-rise apartment assets in Rockville, Md. RESTON, Va., March 31, 2022 (GLOBE NEWSWIRE) — Comstock Holding Companies, Inc. (Nasdaq: CHCI) (“Comstock”) announced results today for its fiscal year ended December 31, 2021. “Comstock’s 2021 was highlighted by growth of assets under management, revenue, and earnings,” said Christopher Clemente, Chairman and CEO. “The premium assets in our Anchor Portfolio continue to provide a foundation for positive top and bottom-line results. Our...

Continue reading

Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2021 Financial Results

Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2021 Financial Results

Company Plans to Initiate Phase 3 Study for TMB-001 in Q2 2022 BASKING RIDGE, NJ, March 31, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today provided a business update and announced financial results for the fourth quarter and year ended December 31, 2021. John Koconis, Chairman and Chief Executive Officer of Timber, commented, “Timber achieved multiple milestones over the past few months. In October, we reported positive topline data for our lead asset TMB-001 and just a few weeks ago, we had a productive follow-up meeting with the FDA, positioning us to launch a Phase 3 study in the second quarter...

Continue reading

Healthier Choices Management Corp. Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results

Healthier Choices Management Corp. Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results

HOLLYWOOD, FL, March 31, 2022 (GLOBE NEWSWIRE) — Healthier Choices Management Corp. (OTC Pink: HCMC) today announced its financial results for the fourth quarter and the year ended December 31, 2021. Fourth Quarter and Full Year Fiscal 2021 Results and Recent Highlights: Total Current Assets for the year ended December 31, 2021, amounted to $28.8 million, compared to $3.0 million, a $25.8million increase when compared to December 31, 2020. Total Current Liabilities for the year ended December 31, 2021, amounted to $2.5 million, compared to $5.7 million, a $3.2 million decrease when compared to December 31, 2020. As a result, the Working Capital improved by roughly $29 million. Net sales from operations for the year ended December 31, 2021, amounted to $13.3 million, compared to $13.9 million, a $0.6 million decrease during the...

Continue reading

Predictive Oncology Reports Year End 2021 Financial Results and Provides Business Update

Predictive Oncology Reports Year End 2021 Financial Results and Provides Business Update

EAGAN, Minn., March 31, 2022 (GLOBE NEWSWIRE) — Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today reported financial results for the year ended December 31, 2021, a period defined by growth, expansion and maturity, and provided an update on business activities. 2021 Highlights: Validated results of subsidiary Helomics’ Discovery 21 proof of concept of its PeDAL® platform, demonstrated ability to make high-confidence predictions in ovarian tumor samples. Added new revenue stream, synergistic customer base and disruptive technology through acquisition of zPREDICTA, Inc., a company pioneering tumor-specific in vitro 3D cell culture models for drug discovery and development. Expanded strategic sales and business development...

Continue reading

Power Solutions International Announces Fourth Quarter and Full Year 2021 Financial Results

Power Solutions International Announces Fourth Quarter and Full Year 2021 Financial Results

WOOD DALE, Ill., March 31, 2022 (GLOBE NEWSWIRE) — Power Solutions International, Inc. (the “Company” or “PSI”) (OTC Pink: PSIX), a leader in the design, engineering and manufacture of emission-certified engines and power systems, announced fourth quarter and full year 2021 financial results. Fourth Quarter 2021 Results Sales for the fourth quarter of 2021 were $127.0 million, an increase of $22.0 million, or 21%, versus the comparable period last year. The improvement in sales is comprised of increases of approximately $8.3 million, $7.9 million, and $5.8 million in the transportation, industrial and power systems (formerly energy) end markets, respectively. Higher transportation end market sales were primarily driven by increased sales in the medium duty truck market due to the continued sell down and exhaustion of certain 6.0L...

Continue reading

Hill International Reports Fourth Quarter and Full Year 2021 Financial Results

Hill International Reports Fourth Quarter and Full Year 2021 Financial Results

Provides 2022 Financial Guidance Fourth Quarter 2021 Overview Consulting Fee Revenue (“CFR”) rose 8.0% to $77.9 million from $72.2 million in the fourth quarter of 2020 New contract awards totaled $162.4 million, producing a book-to-burn ratio of 208.4% Net loss of $2.3 million, or $0.04 per share, compared to net loss of $1.8 million, or $0.03 per share, in last year’s fourth quarter Adjusted net income (a non-GAAP measure) improved to $0.3 million from an adjusted net loss $0.7 million for the same period last year Adjusted EBITDA (a non-GAAP measure) of $5.2 million, compared to $5.7 million in the fourth quarter 2020 Full Year 2021 Overview CFR rose to $305.1 million from $296.6 million in 2020 New contract awards totaled $436.9 million, producing a book-to-burn ratio of 143.2% Net loss narrowed to $4.3 million, or $0.07 per...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.